Three-Pronged attack on tough stomach tumors
NCT ID NCT07072351
Summary
This study is testing a new combination treatment for people with a type of stomach cancer that is advanced but hasn't spread to distant organs. The goal is to see if adding a shorter, more intense course of radiation to standard immunotherapy and chemotherapy can shrink tumors enough to make surgery possible. Researchers will first check if the combination is safe, then measure how well it works at reducing tumor size.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Seventh People's Hospital of Chengdu
RECRUITINGChengdu, Sichuan, 610041, China
-
West China Hospital, Sichuan University
RECRUITINGChengdu, Sichuan, 610041, China
-
West China Shangjin Nanfu Hospital, Sichuan University
RECRUITINGChengdu, Sichuan, 610041, China
-
West China Xiamen Hospital, Sichuan University
RECRUITINGXiamen, Fujian, China
Conditions
Explore the condition pages connected to this study.